• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

eXoZymes Inc. - Common Stock (NQ:EXOZ)

11.70 +0.30 (+2.63%)
Streaming Delayed Price Updated: 3:58 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,094
Open 11.00
Bid (Size) 11.50 (100)
Ask (Size) 11.75 (1,000)
Prev. Close 11.40
Today's Range 10.95 - 13.40
52wk Range 7.080 - 18.40
Shares Outstanding 8,387,250
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
Today 9:10 EDT
Via ACCESS Newswire
News headline image
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
March 31, 2026
Via ACCESS Newswire

Performance

YTD
+6.5%
+6.5%
1 Month
+60.3%
+60.3%
3 Month
+20.9%
+20.9%
6 Month
-13.3%
-13.3%
1 Year
+3.4%
+3.4%

More News

Read More
News headline image
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
March 25, 2026
Via ACCESS Newswire
News headline image
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
March 18, 2026
Via ACCESS Newswire
News headline image
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
March 12, 2026
Via ACCESS Newswire
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
News headline image
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
February 10, 2026
Via ACCESS Newswire
News headline image
eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run
January 29, 2026
Via ACCESS Newswire
News headline image
eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion
December 11, 2025
Via ACCESS Newswire
News headline image
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
November 13, 2025
Via ACCESS Newswire
News headline image
eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff
November 13, 2025
Via ACCESS Newswire
News headline image
eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST
November 10, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 31, 2025
Via Benzinga
News headline image
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference
October 30, 2025
Via ACCESS Newswire
News headline image
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
October 29, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 24, 2025
Via Benzinga
News headline image
CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference
October 23, 2025
Via ACCESS Newswire
News headline image
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees
September 30, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
September 10, 2025
Via Benzinga
News headline image
eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today
August 12, 2025
Via ACCESS Newswire
News headline image
eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST
August 07, 2025
Via ACCESS Newswire
News headline image
eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity
July 29, 2025
Via ACCESS Newswire
News headline image
eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months
July 22, 2025
Via ACCESS Newswire
News headline image
eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing
June 26, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
May 30, 2025
Via Benzinga

Frequently Asked Questions

Is eXoZymes Inc. - Common Stock publicly traded?
Yes, eXoZymes Inc. - Common Stock is publicly traded.
What exchange does eXoZymes Inc. - Common Stock trade on?
eXoZymes Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for eXoZymes Inc. - Common Stock?
The ticker symbol for eXoZymes Inc. - Common Stock is EXOZ on the Nasdaq Stock Market
What is the current price of eXoZymes Inc. - Common Stock?
The current price of eXoZymes Inc. - Common Stock is 11.70
When was eXoZymes Inc. - Common Stock last traded?
The last trade of eXoZymes Inc. - Common Stock was at 04/10/26 03:58 PM ET
What is the market capitalization of eXoZymes Inc. - Common Stock?
The market capitalization of eXoZymes Inc. - Common Stock is 98.13M
How many shares of eXoZymes Inc. - Common Stock are outstanding?
eXoZymes Inc. - Common Stock has 98M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap